MAPT and Alzheimer disease: COVID19 has been shown to exacerbate AD symptoms potentially via modulating the expression of inflammatory proteins and compounding the already dysfunctional neurons by causing a proinflammatory microenvironment in areas with hallmark tau and Aβ accumulation [175, 176].